期刊文献+

鼠疫杆菌YscF抗原基因在大肠杆菌中的表达及鉴定 被引量:1

Expression and identification of YscF antigen gene of Yersinia pestis in E.coli
在线阅读 下载PDF
导出
摘要 为了克隆表达鼠疫耶尔森氏菌的YscF抗原基因,并对其免疫原性进行初步研究,将PCR扩增的YscF基因连接到pMD-18T载体,测序正确后再将YscF基因连接到表达载体PET32a,构建PET32a-YscF重组质粒,并在大肠杆菌BL21(DE3)中诱导表达;诱导表达蛋白采用Ni2+亲和层析法纯化,Western blot检测其免疫原性。结果显示,28 ku的PET32a-YscF融合蛋白能被兔抗鼠的多抗识别,说明表达产物具有良好的抗鼠疫抗原特异性。 YscF gene of Yersinia pestis was cloned and expressed,and preliminary study on immunogenicity of recombinant protein YscF was carried out.YscF gene was inserted into pMD-18T vector after sequence correction,and recombinant expression plasmid PET32a-YscF was constructed by inserting YscF into PET32a and induced with IPTG;the target protein was purified by Ni2+ affinity chromatography;immunogenicity was detected by Western blot.The results indicated that the 28 ku expressed protein could be recognized by Yersinia pestis positive serum as expected.It's proved that recombinant YscF is a possible alternative or adjunct protective vaccine antigen against plague.So YscF is an important protective antigen of Y.pestis.
出处 《西北农林科技大学学报(自然科学版)》 CSCD 北大核心 2007年第11期19-23,共5页 Journal of Northwest A&F University(Natural Science Edition)
关键词 鼠疫耶尔森氏菌 YscF抗原 克隆表达 Yersinia pestis YscF antigen cloning expression
  • 相关文献

参考文献14

二级参考文献65

  • 1郑文岭,马文丽.消化道基因治疗:中医药治疗机制的探讨[J].科技导报,1994,12(12):8-11. 被引量:18
  • 2[2]Andrews GP, Heath DG, Anderson GW, et al. Fraction 1capsular antigen(F1) purification from Yersinia pestis CO92and an Escherichia coli recombinant strain and efficacy against lethal plague challenge [ J ]. Infect Immun, 1996, 64 (6):2 180-2 187.
  • 3[3]Titball RW, Howells AM, Oyston PC, et al. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of the aroA mutant of Salmonella typhimurium induces high levels of protection against plague [J]. Infect immun,1997,65(5): 1 926 - 1 930.
  • 4[4]Leary SE, Williamson ED, Griffin KF, et al. Active immunization with recombinant V antigen from Yersinia pestis protect mice against plague[J]. Infect Immunol, 1995, 63(8):2 854 - 2 858.
  • 5[5]Williamson ED, Sharp G J, Eley SM, et al. Local and system immune response to a microencapsulated sub-unit vaccine for plague[J]. Vaccine, 1996,14(17/18): 1 613- 1 619.
  • 6[6]Eyles JE,Williamson ED, Spiers ID, et al. Protection studies following bronchopulmonary and intramuscular immunization with Y. pestis F1 and V sub-unit vaccine coencapsulated in biodegradable microspheres: a comparsion of efficacy [J].Vaccine, 2000,18(28): 3 266 - 3 271.
  • 7[7]Leary SE,Griffin KF, Gannory HS, et al. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague [ J]. Microbial Pathogenesis, 1997, 23(3): 167 - 179.
  • 8[8]Health DG, Anderson JW, Mauro JM, et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine [J]. Vaccine,1998, 16 (11/12): 1 131- 1 137.
  • 9Comelis GR, Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for sobverting eukaryotic cells[J]. Mol Microbiol 1997,23(5):861-867.
  • 10Pettersson J, Holmstrom A, Hill J, et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation[J]. Mol Microbiol 1999 ,32(5):961-976.

共引文献23

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部